SRTAINTY
LIVE

Serial Number

99645242

Owner

SRT Therapeutics, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Feb 10, 2026

Add to watchlist:

No watchlists yet
View on USPTO

SRTAINTY Trademark

Serial Number: 99645242

SRTAINTY is a trademark filed by SRT Therapeutics, Inc. on February 10, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SRT Therapeutics, Inc. (4 trademarks)

5601 Oberlin Drive, 100
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

February 10, 2026

Registration Date

Not Registered

Goods & Services

Downloadable software for interacting and managing a database; Downloadable software featuring a database of clinical and genomic data for use in scientific research, pharmaceutical development, diagnostics, and medicine

Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, and Inflammatory Bowel Disease; pharmaceutical preparations for the treatment of oncological, cardiovascular, metabolic, autoimmune, inflammatory, infectious, neurological, psychiatric, respiratory, dermatological, musculoskeletal, hematological, ophthalmological, and endocrine diseases and disorders; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use; pharmaceutical preparations for gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine

Disease management services; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, and Inflammatory Bowel Disease; providing health information in the fields of oncological, cardiovascular, metabolic, autoimmune, inflammatory, infectious, neurological, psychiatric, respiratory, dermatological, musculoskeletal, hematological, ophthalmological, and endocrine diseases and disorders; providing information relating to medical diagnostic testing; providing information relating to treatment recommendation; medical consultation; providing a website featuring information about services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, and Inflammatory Bowel Disease; providing a website featuring information about services for the diagnosis, prevention, and treatment of oncological, cardiovascular, metabolic, autoimmune, inflammatory, infectious, neurological, psychiatric, respiratory, dermatological, musculoskeletal, hematological, ophthalmological, and endocrine diseases and disorders; providing health information in the fields of gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine; providing personalized healthcare and medical information in the nature of gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine

Medical laboratory services, namely, laboratory testing, medical diagnostic testing, evaluation, and medical research services; medical laboratory services, namely, laboratory testing in the field of disease management and pathology and of patient diagnosis and patient selection; laboratory testing services to provide specific precision medicine test results; clinical and medical research in the fields of gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine

Filing History

APPLICATION FILING RECEIPT MAILED
Feb 10, 2026 MAFR
NEW APPLICATION ENTERED
Feb 10, 2026 NWAP